Copyright © 2017 Albuquerque Journal
Ovarian cancer is tough to diagnose, and even multiple treatments with chemotherapy too often fail to provide long-term survival for women with the disease.
A new treatment now in clinical trials at the University of New Mexico Comprehensive Cancer Center is intended to train the body’s own immune system to recognize ovarian tumors and attack them – an effect called a “memory response.”
“The goal of the immunotherapy is to induce a memory response,” said Dr. Sarah Adams, who is leading the clinical trial. “One of the most exciting things about immunotherapy is the idea that we could teach the immune system to recognize cancer and prevent cancer recurrence.”